{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:49:14Z","timestamp":1776217754874,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJST1917"],"award-info":[{"award-number":["JPMJST1917"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.heliyon.2023.e14392","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T03:52:39Z","timestamp":1678333959000},"page":"e14392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A comparative study between a transscleral sustained-release device and eyedrops on intraocular distribution of carteolol hydrochloride"],"prefix":"10.1016","volume":"9","author":[{"given":"Yoshiko","family":"Hashikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-4172","authenticated-orcid":false,"given":"Hirokazu","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2826-4959","authenticated-orcid":false,"given":"Nobuhiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.heliyon.2023.e14392_bib1","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.biomaterials.2010.11.006","article-title":"A scalable controlled-release device for transscleral drug delivery to the retina","volume":"32","author":"Kawashima","year":"2011","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14392_bib2","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.actbio.2013.11.004","article-title":"A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye","volume":"10","author":"Nagai","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.heliyon.2023.e14392_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2017.07.002","article-title":"Drug delivery devices for retinal diseases","volume":"128","author":"Kaji","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e14392_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10856-017-5919-2","article-title":"Physicochemical and biological characterization of sustained isopropyl unoprostone-release device made of poly(ethyleneglycol) dimethacrylates","volume":"28","author":"Nagai","year":"2017","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14392_bib5","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1167\/iovs.17-22429","article-title":"Pharmacokinetic and safety evaluation of a transscleral sustained unoprostone release device in monkey eyes","volume":"59","author":"Nagai","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"15","key":"10.1016\/j.heliyon.2023.e14392_bib6","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1167\/iovs.16-20453","article-title":"Long-term protection of genetically ablated rabbit retinal degeneration by sustained transscleral unoprostone delivery","volume":"57","author":"Nagai","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.heliyon.2023.e14392_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118458","article-title":"Transscleral sustained ranibizumab delivery using an episcleral implantable device: suppression of laser-induced choroidal neovascularization in rats","volume":"567","author":"Nagai","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e14392_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058580","article-title":"Transscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularization","volume":"8","author":"Onami","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14392_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1208\/s12249-020-1622-6","article-title":"Bimatoprost imprinted silicone contact lens to treat glaucoma","volume":"21","author":"Yan","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14392_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1089\/jop.2018.0096","article-title":"Co-delivery of timolol and brimonidine with a polymer thin-film intraocular device","volume":"35","author":"Samy","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"24","key":"10.1016\/j.heliyon.2023.e14392_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900702","article-title":"Dendritic effects of injectable biodegradable thermogels on pharmacotherapy of inflammatory glaucoma-associated degradation of extracellular matrix","volume":"8","author":"Nguyen","year":"2019","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14392_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/10717540500309073","article-title":"Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride","volume":"13","author":"El-Kamel","year":"2006","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e14392_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/jop.2011.0101","article-title":"Effects of a long-acting ophthalmic formulation of carteolol containing alginic acid on the corneal epithelial barrier function and water retentive effect","volume":"28","author":"Tokuda","year":"2012","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e14392_bib14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00002512-200724060-00007","article-title":"Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension","volume":"24","author":"Henness","year":"2007","journal-title":"Drugs Aging"},{"issue":"11","key":"10.1016\/j.heliyon.2023.e14392_bib15","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","article-title":"Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling","volume":"58","author":"Ranta","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e14392_bib16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/adhm.201400114","article-title":"A platform for controlled dual-drug delivery to the retina: protective effects against light-induced retinal damage in rats","volume":"3","author":"Nagai","year":"2014","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14392_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/jop.2018.0067","article-title":"Intracameral sustained-release bimatoprost implant delivers bimatoprost to target tissues with reduced drug exposure to off-target tissues","volume":"35","author":"Seal","year":"2019","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e14392_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/WCO.0000000000000777","article-title":"Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions","volume":"33","author":"Gokoffski","year":"2020","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.heliyon.2023.e14392_bib19","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1080\/02713683.2020.1715446","article-title":"The sustained release of tafluprost with a drug delivery system prevents the axonal injury-induced loss of retinal ganglion cells in rats","volume":"45","author":"Sato","year":"2020","journal-title":"Curr. Eye Res."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023015992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023015992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:52:02Z","timestamp":1776214322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023015992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2405844023015992"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14392","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study between a transscleral sustained-release device and eyedrops on intraocular distribution of carteolol hydrochloride","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e14392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e14392"}}